Russia says unnamed US firm violated patent rights on Sputnik V vaccine
RDIF, which actively markets Sputnik V abroad, did not disclose the name of the US firm
Russia's RDIF sovereign wealth fund said on Monday a US firm had violated Russian patent rights on its Sputnik V vaccine against Covid-19.
RDIF, which actively markets Sputnik V abroad, did not disclose the name of the US firm.